Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.7590
-0.0610 (-7.44%)
At close: Jun 27, 2025, 4:00 PM
0.7450
-0.0140 (-1.84%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $1.54 million as of June 27, 2025. Its market cap has decreased by -58.62% in one year.
Market Cap
1.54M
Enterprise Value
-2.16M
1-Year Change
-58.62%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.67M to $1.54M, a decrease of -98.30%. That is a compound annual growth rate of -58.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 1.66M | -56.79% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.48% |
| Dec 30, 2022 | 4.47M | -93.31% |
| Dec 31, 2021 | 66.83M | -28.42% |
| Dec 31, 2020 | 93.37M | 2.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |